SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-22-020516
Filing Date
2022-12-23
Accepted
2022-12-23 16:05:16
Documents
12
Period of Report
2022-12-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K organicellregen_8k.htm   iXBRL 8-K 22954
  Complete submission text file 0001829126-22-020516.txt   190299

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocel-20221221.xsd EX-101.SCH 3233
3 XBRL LABEL FILE ocel-20221221_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocel-20221221_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT organicellregen_8k_htm.xml XML 3296
Mailing Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 221485395
SIC: 2836 Biological Products, (No Diagnostic Substances)